Professional Documents
Culture Documents
www.elsevier.com/locate/jns
Abstract
The concept of Vascular Cognitive Impairment (VCI) encompasses patients across the entire continuum of cognitive impairment resulting
from cerebrovascular disease (CVD), ranging from high-risk patients with no frank cognitive deficit (the bbrain-at-riskQ stage) through
vascular dementia (VaD).
There are accepted differences in the neuropsychological profile of patients with Alzheimers disease (AD) and VaD. In patients with
VaD, executive functions that tend to be disproportionately impaired include planning and sequencing, speed of mental processing,
performance on unstructured tasks, and attention. Language production may be impaired in patients with VaD but primary language functions
otherwise tend to be preserved. Patients with VaD also exhibit significantly more perseverations than patients with AD. Memory impairment
is typically evident in patients with AD+CVD but memory impairment may also occur as a primary consequence of stroke in the posterior
cerebral artery territory with involvement of the medial temporal lobe, or as a secondary consequence of a cognitive syndrome involving
inattention due to primary executive dysfunction.
Compared to VaD, patients with AD may exhibit greater deficits in functions (including memory) mediated by posterior cortical
structures, such as the temporal and parietal lobes. AD patients exhibit a faster rate of information decay, reduced ability to benefit from cues
to facilitate retrieval, and higher frequency of intrusion errors; in addition, certain aspects of language function, such as naming, may
exacerbate deficits on verbal memory tasks. AD tends to affect lexicon while VaD tends to affect syntax. When patients with AD exhibit
perseverations, they tend to be elicited by tests of semantic knowledge.
D 2004 Elsevier B.V. All rights reserved.
Keywords: Neuropsychology; Vascular cognitive impairment; Cognitive deficit
1. Introduction
Vascular Cognitive Impairment (VCI) [1] is a broad
concept that encompasses patients across the entire
continuum of cognitive impairment resulting from cerebrovascular disease (CVD), ranging from high-risk
patients with no frank cognitive deficit (the bbrain-atriskQ stage) through severe dementia (vascular dementia,
VaD). In proposing that concept, Hachinski argued that
there is little agreement regarding the methods for the
6. Future studies
In the future, studies of cognitive patterns should focus on
patients with VCI who do not meet formal dementia criteria,
perhaps specifically those with subcortical CVD in order to
maximize the homogeneity of the cohort. An appropriate
reference group would be patients with Mild Cognitive
Impairment (MCI) [15] or incipient dementia that would
most likely be due to AD, but the standard criteria for MCI
that require memory impairment should be broadened to
permit any cognitive deficit to render patients eligible.
Neuropsychological testing should be performed in conjunction with structural and functional brain imaging in order
to identify relationships between specific cognitive deficits
and specific structural and metabolic abnormalities. Studies
should include long-term follow-up in order to assess the
comparative evolution of cognitive deficits.
Why is it better to study patients with VCI who are
non-demented rather than demented patients? First, unlike
MCI and dementia, memory impairment is not required
for the diagnosis of VCI, eliminating a source of
recognition bias. Second, less severely affected patients
will be more likely to demonstrate a subtle cognitive
deficit specific to the frontal lobes. Third, VCI patients
may be more testable than patients with dementia on
complex and challenging frontal tests, permitting deficits
to be assessed and recognized. Finally, it is likely that
non-demented patients with VCI, that is, those patients
who are at risk of progression to dementia, would be the
most appropriate candidates for clinical trials, and it will
be important to fully understand their clinical characteristics both at baseline and during long-term follow-up.
Acknowledgments
This work was supported by Grants R01-NS26179 and
K07-AG00959 from the National Institutes of Health.
References
[1] Hachinski V. Vascular dementia: a radical redefinition. Dementia
1994;5:130 2.
[2] Desmond DW, Erkinjuntti T, Sano M, Cummings JL, Bowler JV,
Pasquier F, et al. The cognitive syndrome of vascular dementia:
implications for clinical trials. Alzheimer Dis Assoc Disord
1999;13(Suppl 3):S21 9.
[3] Looi JCL, Sachdev PS. Differentiation of vascular dementia from AD
on neuropsychological tests. Neurology 1999;53:670 8.
[11]
[12]
[13]
[14]
[15]